Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?
YH Ku, WL Yu - Infection, Genetics and Evolution, 2021 - Elsevier
Sulbactam, a class A β-lactamase inhibitor, added to cefoperazone either at a fixed 8 mg/L
level of sulbactam or at a level of fixed cefoperazone: sulbactam ratio (2: 1) would constitute …
level of sulbactam or at a level of fixed cefoperazone: sulbactam ratio (2: 1) would constitute …
Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms
CC Lai, CC Chen, YC Lu, TP Lin… - Infection and Drug …, 2018 - Taylor & Francis
Objectives: This study aims to assess the in vitro activity of different cefoperazone–
sulbactam ratios against different multidrug-resistant organisms (MDROs). Materials and …
sulbactam ratios against different multidrug-resistant organisms (MDROs). Materials and …
Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam
CC Knapp, J Sierra-Madero, JA Washington - Diagnostic microbiology and …, 1990 - Elsevier
Cefoperazone with 2 and 4 μg/ml of sulbactam and in a 2: 1 ratio was tested against 1258
clinical isolates of Gram-positive and Gram-negative bacteria, as well as against Gram …
clinical isolates of Gram-positive and Gram-negative bacteria, as well as against Gram …
In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and β-lactamase studies
RN Jones, HW Wilson, C Thornsberry… - … microbiology and infectious …, 1985 - Elsevier
Cefoperazone was tested against 554 clinical isolates alone and with sulbactam in three
combinations. The addition of sulbactam in low concentrations (≤ 4 µg/ml) improved the …
combinations. The addition of sulbactam in low concentrations (≤ 4 µg/ml) improved the …
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and …
RJ Fass, WW Gregory, RF D'amato… - Antimicrobial agents …, 1990 - Am Soc Microbiol
Among 28,000 isolates of the family Enterobacteriaceae and nonfermenters isolated at
multiple medical centers, 1,084 (4%) were resistant to cefoperazone (MIC, greater than or …
multiple medical centers, 1,084 (4%) were resistant to cefoperazone (MIC, greater than or …
In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins
H Bijie, S Kulpradist, M Manalaysay… - Journal of …, 2005 - europepmc.org
Due to their wide spectrum of activity, good pharmacokinetics, established clinical efficacy
and high tolerability, cephalosporins are among the most widely used antibiotics worldwide …
and high tolerability, cephalosporins are among the most widely used antibiotics worldwide …
β-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone
JD Williams - Clinical infectious diseases, 1997 - academic.oup.com
Abstract β-Lactamase inhibitors such as sulbactam are (β-lactam compounds that have low
antimicrobial activity but are able to inhibit enzymes (β-lactamases) that destroy j3-lactam …
antimicrobial activity but are able to inhibit enzymes (β-lactamases) that destroy j3-lactam …
The Cefoperazone–Sulbactam Combination: In Vitro Qualities Including Beta-Lactamase Stability, Antimicrobial Activity, and Interpretive Criteria for Disk Diffusion …
RN Jones, AL Barry, C Thornsberry… - American journal of …, 1985 - academic.oup.com
Three concentrations of the penicillanic acid sulfone, sulbactam were tested in combination
with cefoperazone against 632 recent clinical bacterial isolates. Cefoperazone was effective …
with cefoperazone against 632 recent clinical bacterial isolates. Cefoperazone was effective …
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections
DW Wareham, MHFA Momin, LM Phee… - Journal of …, 2020 - academic.oup.com
Abstract Background β-Lactam (BL)/β-lactamase inhibitor (BLI) combinations are widely
used for the treatment of Gram-negative infections. Cefepime has not been widely studied in …
used for the treatment of Gram-negative infections. Cefepime has not been widely studied in …
[HTML][HTML] The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
PC Chang, CC Chen, YC Lu, CC Lai, HL Huang… - Journal of microbiology …, 2018 - Elsevier
Objectives This study aims to assess the in vitro activity of cefoperazone alone and different
cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant …
cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant …